Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
Abroad (travel likely)RecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
T Cell Lymphoma · T-cell Lymphoma
Locations
- Yale Cancer Center, Clinical Trials Office, New Haven, Connecticut, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States